Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
It is known that more or less pronounced impairment of pulmonary function occurs after anesthesia. It has been demonstrated in the postoperative period in both patients undergoing general and regional anesthesia, in patients after intra-abdominal and superficial procedures, in overweight and normal-weight patients. It has also been shown that when general anesthesia is performed with the inhalation anesthetic sevoflurane, there is a slightly smaller reduction in lung function parameters than when only intravenous anesthetics are used.
The purpose of this study is to evaluate lung function before induction and after awakening from general anesthesia depending on the inhalational anesthetic used in obese patients undergoing bariatric surgery
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| General anesthesia with desflurane | Experimental | Patients undergoing anesthesia for bariatric surgery with desflurane as a volatile agent. |
|
| General anesthesia with sevoflurane | Experimental | Patients undergoing anesthesia for bariatric surgery with sevoflurane as a volatile agent. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Different drug type for conduction of general anesthesia | Drug | Patients will be randomly divided into two groups: patients for whom general anesthesia will be performed with sevoflurane and patients for whom general anesthesia will be performed with desflurane. |
| Measure | Description | Time Frame |
|---|---|---|
| Heart rate (HR) | HR will be measured by ecg in beat per minute | Continuously during whole duration of anesthesia |
| Pulse oximetry (SpO2) | SpO2 will be measured by light spectrometry percutaneous sensor in % | Continuously during whole duration of anesthesia |
| End tidal CO2 (etCO2) | etCO2 will be measured by capnography with infrared radiation sensor in mmHg. Sensor will be attached to breathing circuit. | Continuously during whole duration of anesthesia |
| Minimum alveolar concentration (MAC) | MAC will be measured based on exhaled anesthetic gas concentration in absolute numbers | Continuously during whole duration of anesthesia |
| Bispectral index (BIS) | BIS will be measured with Covidien BIS monitoring system in absolute numbers | Continuously during whole duration of anesthesia |
| Train of for (TOF) | TOF will be measured in absolute numbers | Every 2.5 minutes during whole duration of anesthesia |
| Non invasive blood pressure (NIBP) | NIBP will be measured with oscillometric method in mmHG | Every 5 minutes during whole duration of anesthesia |
| Forced vital capacity (FVC) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Patients who have absolute contraindications to spirometry testing, i.e:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Karolina Obara, MD | Contact | 0048 58 349 32 80 | kobara@uck.gda.pl |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Clinical Center | Recruiting | Gdansk | Poland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
FVC will be measured with spirometry |
| 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| Volume that has been exhaled at the end of the first second of forced expiration (FEV1) | FEV1 will be measured with spirometry | 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| Mid-expiratory flow; the rates at 25% FVC (MEF25) | MEF25 will be measured with spirometry | 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| Mid-expiratory flow; the rates at 25% FVC (MEF50) | MEF50 will be measured with spirometry | 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| Peak expiratory flow (PEF) | PEF will be measured with spirometry | 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| Respiratory input impedance (Zrs) | Zrs will be measured with impulsed oscillometry | 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| Resistive component (Rrs) | Rrs will be measured with impulsed oscillometry | 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| Reactive component (Xrs) | Xrs will be measured with impulsed oscillometry | 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| Resonant frequency (Fres) | Fres will be measured with impulsed oscillometry | 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| Area of reactance (Ax) | Ax will be measured with impulsed oscillometry | 3 months before the surgery and 10 and 30 minutes after the emergence from general anesthesia |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |